Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Knight Therapeutics (TSE:GUD)

TSX:GUD

GUD

Knight Therapeutics

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding TSE:GUD?

Track your performance easily

Link Broker

Knight Therapeutics (GUD) Income Statement

90 Followers

Knight Therapeutics Income Statement

Last quarter (Q2 2024), Knight Therapeutics's total revenue was C$95.57M, an increase of 6.30% from the same quarter last year. In Q2, Knight Therapeutics's net income was C$-1.94M. See Knight Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	C$ 337.87M	C$ 328.20M	C$ 293.56M	C$ 243.48M	C$ 199.52M	C$ 47.46M
Cost of Revenue	C$ 174.44M	C$ 175.55M	C$ 155.50M	C$ 128.07M	C$ 117.83M	C$ 20.54M
Gross Profit	C$ 163.43M	C$ 152.65M	C$ 138.06M	C$ 115.41M	C$ 81.69M	C$ 26.92M
Operating Expense	C$ 155.34M	C$ 146.28M	C$ 155.12M	C$ 128.24M	C$ 111.69M	C$ 39.58M
Operating Income	C$ 8.10M	C$ 6.37M	C$ -17.06M	C$ -12.83M	C$ -30.00M	C$ -12.66M
Net Non Operating Interest Income Expense	C$ -193.00K	C$ 87.00K	C$ 4.03M	C$ -3.76M	C$ -10.92M	C$ -23.17M
Other Income Expense	C$ -24.07M	C$ -28.45M	C$ 14.39M	C$ 15.76M	C$ 51.16M	C$ 12.27M
Pretax Income	C$ -23.68M	C$ -21.99M	C$ -58.84M	C$ 6.69M	C$ 32.09M	C$ 22.78M
Tax Provision	C$ -2.46M	C$ -5.15M	C$ -14.07M	C$ -8.98M	C$ 325.00K	C$ 4.75M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	C$ 906.00K
Net Income Common Stockholders	C$ -21.23M	C$ -16.84M	C$ -44.78M	C$ 15.68M	C$ 42.07M	C$ 14.52M
Basic EPS	C$ -0.20	C$ -0.16	C$ -0.26	C$ 0.13	C$ 0.32	C$ 0.10
Diluted EPS	C$ -0.21	C$ -0.16	C$ -0.26	C$ 0.13	C$ 0.32	C$ 0.10
Basic Average Shares	C$ 412.37M	C$ 107.47M	C$ 114.89M	C$ 124.48M	C$ 131.78M	C$ 139.76M
Diluted Average Shares	C$ 412.17M	C$ 107.47M	C$ 114.89M	C$ 124.52M	C$ 131.99M	C$ 140.14M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 329.78M	C$ 321.83M	C$ 310.62M	C$ -256.31M	C$ -229.52M	C$ -60.12M
Net Income From Continuing And Discontinued Operation	C$ -21.23M	C$ -16.84M	C$ -44.78M	C$ 15.68M	C$ 42.07M	C$ 14.52M
Normalized Income	C$ -19.24M	C$ -17.88M	C$ -48.93M	C$ -2.72M	C$ 22.73M	C$ 21.15M
Interest Expense	-	-	-	-	-	-
EBIT	C$ -12.13M	C$ -9.50M	C$ -52.24M	C$ 10.31M	C$ 35.48M	C$ 23.15M
EBITDA	C$ 38.77M	C$ 40.90M	C$ 10.38M	C$ 58.22M	C$ 67.56M	C$ 27.42M

Currency in CAD

Knight Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing